Breast cancer genomic test could spare millions from chemotherapy
BY THE OPTIMIST DAILY EDITORIAL TEAM For decades, high clinical risk and chemotherapy arrived together as a package deal in early breast cancer. A trial presented at the American Society of Clinical Oncology meeting in Chicago on May 30, 2026, is pulling them apart. The OPTIMA trial enrolled more than 4,400 patients across the United Kingdom, all with early-stage estrogen receptor-positive, HER2-negative breast cancer flagged as high clinical risk by conventional measures. The question was wheth
The science section covers breakthroughs in medicine, physics, biology, and technology. We surface discoveries that expand what humanity can do, from new treatments reaching clinical trials to engineering feats that seemed impossible a decade ago. Every link goes to the original publisher so you can read the full study or press release yourself.
BY THE OPTIMIST DAILY EDITORIAL TEAM Picture two parents, both devoted. Both called every Sunday. Both showed up for bir…
Earth Observatory Science International Space Station (ISS) San Francisco’s Metropolitan… Earth Earth Observatory Image …
Researchers tested soccer balls aboard the International Space Station to study how internal mass affects motion and sta…
NASA/Lori Losey On June 5, 2026, NASA’s experimental X-59 aircraft flew faster than the speed of sound for the first tim…